Elisabet Jerlhag
Overview
Explore the profile of Elisabet Jerlhag including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
2515
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jerlhag E
Endocrinology
. 2025 Feb;
166(4).
PMID: 39980336
Glucagon-like peptide-1 (GLP-1) is abundant in the circulation, and it is well-known to regulate glucose homeostasis, feeding, and body weight. GLP-1 receptor agonists are therefore approved for treating type 2...
2.
Aranas C, Edvardsson C, Zentveld L, Vallof D, Witley S, Tufvesson-Alm M, et al.
Acta Neuropsychiatr
. 2024 Dec;
:1-15.
PMID: 39639536
Objective: Combining different pharmaceuticals may be beneficial when treating disorders with complex neurobiology, including alcohol use disorder (AUD). The gut-brain peptides amylin and GLP-1 may be of potential interest as...
3.
Aranas C, Caffrey A, Edvardsson C, Vestlund J, Schmidt H, Jerlhag E
Br J Pharmacol
. 2024 Dec;
182(6):1292-1305.
PMID: 39622492
Background And Purpose: The limited effectiveness of current pharmacological treatments for alcohol use disorder (AUD) highlights the need for novel therapies. These may involve the glucagon-like peptide-1 receptor or the...
4.
Jerlhag E
Int Rev Neurobiol
. 2024 Nov;
178:401-432.
PMID: 39523062
Peptides of the gut-brain axis have gained recent attention as potential treatment targets for addiction. While the number of gut-brain peptides is vast, ghrelin and glucagon-like peptide-1 (GLP-1) have been...
5.
Tufvesson-Alm M, Aranas C, Blid Skoldheden S, Vestlund J, Edvardsson C, Jerlhag E
Transl Psychiatry
. 2024 Oct;
14(1):401.
PMID: 39358354
The underlying neurobiology of alcohol use disorder (AUD) is complex and needs further unraveling, with one of the key mechanisms being the gut-brain peptide ghrelin and its receptor (GHSR). However,...
6.
Edvardsson C, Vestlund J, Ericson M, Jerlhag E
Front Pharmacol
. 2024 Sep;
15:1439203.
PMID: 39221138
The physiological effects of glucagon-like peptide-1 (GLP-1) are mainly centered on its ability to decrease blood glucose levels and facilitate satiety. Additional physiological functions have been identified by means of...
7.
Ruiz M, Devkota R, Bergh P, Nik A, Blid Skoldheden S, Mondejar-Duran J, et al.
FASEB J
. 2024 Jul;
38(14):e23815.
PMID: 38989587
To investigate how the fatty acid composition of brain phospholipids influences brain-specific processes, we leveraged the AdipoR2 (adiponectin receptor 2) knockout mouse model in which the brain is enlarged, and...
8.
Witley S, Edvardsson C, Aranas C, Tufvesson-Alm M, Stalberga D, Green H, et al.
Transl Psychiatry
. 2024 Jul;
14(1):277.
PMID: 38965230
The mechanisms contributing to alcohol use disorder (AUD) are complex and the orexigenic peptide ghrelin, which enhances alcohol reward, is implied as a crucial modulator. The major proportion of circulating...
9.
Domi A, Cadeddu D, Lucente E, Gobbo F, Edvardsson C, Petrella M, et al.
Neuropsychopharmacology
. 2024 May;
49(12):1851-1860.
PMID: 38755284
The transition to alcohol use disorder (AUD) involves persistent neuroadaptations in executive control functions primarily regulated by the medial prefrontal cortex. However, the neurophysiological correlates to behavioral manifestations of AUD...
10.
Tufvesson-Alm M, Zhang Q, Aranas C, Blid Skoldheden S, Edvardsson C, Jerlhag E
Prog Neurobiol
. 2024 Apr;
236:102615.
PMID: 38641041
The gut-brain peptide ghrelin and its receptor are established as a regulator of hunger and reward-processing. However, the recently recognized ghrelin receptor inverse agonist, liver-expressed antimicrobial peptide 2 (LEAP2), is...